NSC |
Compound |
Enrichment |
Correlation |
NSC 718781 |
Erlotinib hydrochloride |
0.00070132188671658 |
-0.45998638 |
NSC 752506 |
5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide |
0.00070132188671658 |
0.26026077 |
NSC 762346 |
Null |
0.00070132188671658 |
0.58520499 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.000880521445136057 |
0.21947609 |
NSC 633497 |
Null |
0.000880521445136057 |
0.060446688 |
NSC 694269 |
Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate |
0.000880521445136057 |
0.35364552 |
NSC 727048 |
11-(3'-Methylaminopropylidene]-5,6-dihydro-5-keto-2,3-dimeth oxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinolin e |
0.000880521445136057 |
0.12389958 |
NSC 749862 |
3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine |
0.000880521445136057 |
0.24140395 |
NSC 710525 |
Null |
0.000930692338491037 |
0.11374974 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.000931492155975116 |
0.36037349 |